|1.||Jaouen, Gérard: 6 articles (11/2014 - 12/2005)|
|2.||Hillard, Elizabeth A: 4 articles (11/2014 - 02/2009)|
|3.||Vessières, Anne: 4 articles (12/2010 - 12/2005)|
|4.||Pigeon, Pascal: 3 articles (11/2014 - 12/2009)|
|5.||Jiang, Hui: 3 articles (03/2013 - 03/2009)|
|6.||Yan, Hong: 3 articles (03/2013 - 03/2009)|
|7.||Plamont, Marie-Aude: 3 articles (12/2010 - 12/2009)|
|8.||Top, Siden: 3 articles (12/2010 - 12/2009)|
|9.||Schobert, Rainer: 2 articles (09/2014 - 09/2009)|
|10.||Biersack, Bernhard: 2 articles (09/2014 - 09/2009)|
04/01/2011 - "Further investigations into the class of ferrocene-derived agents might reveal compounds with improved activity for a more specific and safe anti-cancer therapy."
03/15/2013 - "Herein, a label-free electrochemical cytosensor with surface-confined ferrocene as signal indicator was developed for highly sensitive and selective detection of cancer cell. "
04/01/2011 - "Here, we show that the ferrocene derivative HUNI 068 is active against cancer cells and overcomes different mechanisms of multiple drug resistance (MDR). "
12/03/2010 - "Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and ferrocenophane tetrasubstituted olefin derivatives against human cancer cells."
03/01/2003 - "This conclusion is supported by adoptive transfer experiments demonstrating that immune cells from ferrocene-treated tumor-bearing mice elicit an antitumor effect in mice not treated with ferrocene. "
03/21/2014 - "In search of effective anti-cancer and anti-malaria hybrids that possess improved properties compared to their parent compounds, a series of novel 1,2,4-trioxane-based hybrids incorporating egonol and/or ferrocene fragments were synthesized and tested in vitro against P. "
03/01/2012 - "Novel conjugates of the antimalarial drug primaquine (compound 1) with ferrocene, named primacenes, have been synthesized and screened for their activities against blood stage and liver stage malaria in vitro and host-vector transmission in vivo. "
01/26/1993 - "The feeding of diets enriched with (3,5,5-trimethylhexanoyl)ferrocene (TMH-ferrocene) has been shown recently to produce a severe experimental iron overload in rats and has been considered as an adequate animal model for hereditary haemochromatosis in humans. "
01/01/1992 - "Iron overload of the bone marrow by trimethylhexanoyl-ferrocene in rats."
06/01/2012 - "An iron-overload condition was induced in genetically altered β-thalassemic mice and adult wild-type mice by feeding them with an iron diet (0.2% ferrocene w/w) for 3 months. "
02/01/2000 - "Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects."
07/01/1999 - "Whereas in normal and in iron-starved rats the high-affinity component was more prominent, it disappeared altogether in hepatocytes from rats with iron overload resulting from prolonged feeding with TMH-ferrocene-enriched diet. "
|4.||Breast Neoplasms (Breast Cancer)
07/01/2013 - "Remarkable anti-breast cancer activity of ferrocene tagged multi-functionalized 1,4-dihydropyrimidines."
08/07/2012 - "We prepared a series of new iminosugar-ferrocene hybrids displaying potent inhibition of fucosidase (bovine kidney) and inactivation of MDA-MB-231 breast cancer cells proliferation at low micromolar concentrations. "
11/01/2007 - "We have shown that the frequency of apoptotic events in MCF-7 breast cancer cells treated with Tam-Fer is significantly higher than in cells treated with tamoxifen or ferrocene separately. "
11/01/2007 - "Tamoxifen, a drug that interacts with oestrogen receptors, was used as a carrier to deliver ferrocene to breast cancer cells. "
11/19/2012 - "Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells."
07/01/2015 - "This article reports comprehensively the comparative DNA binding studies (with, cyclic voltammetry, UV-vis spectroscopy and viscometry), antioxidant activities (DPPH scavenging), anti-inflammatory activities (nitrite inhibition), phase I enzyme inhibition activities (aromatase inhibition), phase II enzyme induction studies (quinone reductase induction) and cytotoxic studies against neuroblastoma (MYCN2 and SK-N-SH), liver cancer (Hepa 1c1c7) and breast cancer (MCF-7) of seventeen ferrocene incorporated selenoureas. "
|6.||DNA (Deoxyribonucleic Acid)
|8.||NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)
|9.||Serotonin (5 Hydroxytryptamine)
|2.||Cardiopulmonary Resuscitation (CPR)